Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Type of study
Publication year range
1.
Horm Metab Res ; 43(13): 938-43, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22109679

ABSTRACT

Maternal factors can have major imprinting effects on homeostatic mechanisms in the developing fetus and newborn. Here we studied whether supplemented perinatal polyunsaturated fatty acids (PUFAs) influence energy balance and fuel homeostasis later in life. Between day 10 after conception and day 10 after delivery, female rats were subjected to chow enriched with 10% fish-oil (FO-rich). Fish oil contains high concentrations of n-3 biosynthesis endpoint products, which may have caused the increased membrane phospholipid incorporation (particularly derived from the long-chain 20 +:n-3 PUFAs) in 10-day old pup brains. Adult male offspring of FO-rich fed rats had reduced body weight (- 20%) at 3 months, and had lower levels of plasma leptin (- 54%), insulin (- 41%), triglycerides (- 65%), and lactate (- 46%) than controls. All differences between groups were lost 48 h after streptozotocin (STZ) treatment. At 4.5 months of age, body weights of FO-rich were still lower (- 6%) than controls, but were associated with increased food intake, and increased insulin sensitivity (following intraperitoneal injection) to lower blood glucose levels relative to controls. We concluded that perinatal FO supplementation has lasting effects on body weight homeostasis and fuel metabolism in male offspring, but does not offer resistance against STZ-induced diabetes.


Subject(s)
Diabetes Mellitus, Experimental/metabolism , Energy Metabolism , Fatty Acids, Unsaturated/administration & dosage , Insulin Resistance , Prenatal Exposure Delayed Effects/metabolism , Animals , Animals, Newborn/growth & development , Animals, Newborn/metabolism , Blood Glucose/metabolism , Female , Humans , Insulin/metabolism , Male , Maternal Nutritional Physiological Phenomena , Pregnancy , Rats , Rats, Wistar
2.
Neurobiol Dis ; 23(3): 563-72, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16765602

ABSTRACT

The present study assessed the influence of dietary lipids on accumulation of amyloid beta-peptide (Abeta) in the brain. Seven experimental diets with varying n-6/n-3-ratio, saturated and polyunsaturated fatty acid and cholesterol contents were fed to transgenic APPswe/PS1dE9 mice for 3-4 months beginning at a young adult age (6 months). Hippocampal Abeta levels were determined with ELISA and plaque load by using immunocytochemistry. A typical Western diet with 40% saturated fatty acids and 1% of cholesterol increased, while diets supplemented with docosahexaenoic acid (DHA) decreased Abeta levels compared to regular (soy oil based) diet. DHA diet also decreased the number of activated microglia in hippocampus and increased exploratory activity of transgenic mice, but did not improve their spatial learning in the water maze. The favorable effect of DHA on Abeta production was verified in two different cell lines. Regulation of dietary lipid intake may offer a new tool to reduce the risk of Alzheimer's disease at the population level.


Subject(s)
Alzheimer Disease/diet therapy , Alzheimer Disease/prevention & control , Amyloid beta-Peptides/biosynthesis , Brain/metabolism , Cholesterol/metabolism , Dietary Fats, Unsaturated/metabolism , Alzheimer Disease/physiopathology , Amyloid beta-Protein Precursor/genetics , Amyloid beta-Protein Precursor/metabolism , Animals , Brain/pathology , Brain/physiopathology , Disease Models, Animal , Docosahexaenoic Acids/metabolism , Encephalitis/physiopathology , Encephalitis/prevention & control , Encephalitis/therapy , Fatty Acids/metabolism , Fatty Acids, Unsaturated/metabolism , Food, Formulated , Gliosis/physiopathology , Gliosis/prevention & control , Gliosis/therapy , Humans , Membrane Proteins/genetics , Membrane Proteins/metabolism , Mice , Mice, Transgenic , Microglia/metabolism , Plaque, Amyloid/metabolism , Plaque, Amyloid/pathology , Presenilin-1 , Treatment Outcome
3.
Neuroscience ; 119(4): 999-1012, 2003.
Article in English | MEDLINE | ID: mdl-12831859

ABSTRACT

Long-chain polyunsaturated fatty acid (LC-PUFA) composition of neural membranes is a key factor for brain development, in chemical communication of neurons and probably also their survival in response to injury. Viability of cholinergic neurons was tested during brain development following dietary supplementation of fish oil LC-PUFAs (docosahexaenoic acid [DHA], eicosapentaenoic acid, arachidonic acid) in the food of mother rats. Excitotoxic injury was introduced by N-methyl-D,L-aspartate (NMDA) injection into the cholinergic nucleus basalis magnocellularis of 14-day-old rats. The degree of loss of cholinergic cell bodies, and the extend of axonal and dendritic disintegration were measured following immunocytochemical staining of cell bodies and dendrites for choline acetyltransferase and p75 low-affinity neurotrophin receptor and by histochemical staining of acetylcholinesterase-positive fibres in the parietal neocortex. The impact of different feeding regimens on fatty acid composition of neural membrane phospholipids was also assayed at 12 days of age. Supplementation of LC-PUFAs resulted in a resistance against NMDA-induced excitotoxic degeneration of cholinergic neurones in the infant rats. More cholinergic cells survived, the dendritic involution of surviving neurons in the penumbra region decreased, and the degeneration of axons at the superficial layers of parietal neocortex also attenuated after supplementing LC-PUFAs. A marked increment in DHA content in all types of phospholipids was obtained in the forebrain neuronal membrane fraction of supplemented rats. It is concluded that fish oil LC-PUFAs, first of all DHA, is responsible for the neuroprotective action on developing cholinergic neurons against glutamate cytotoxicity.


Subject(s)
Docosahexaenoic Acids/pharmacology , Nerve Degeneration/drug therapy , Nerve Degeneration/prevention & control , Neurons/drug effects , Neuroprotective Agents/pharmacology , Neurotoxins/antagonists & inhibitors , Prenatal Exposure Delayed Effects , Prenatal Nutritional Physiological Phenomena/physiology , Acetylcholinesterase/metabolism , Animals , Axons/drug effects , Axons/metabolism , Axons/pathology , Basal Nucleus of Meynert/drug effects , Basal Nucleus of Meynert/growth & development , Basal Nucleus of Meynert/metabolism , Choline O-Acetyltransferase/metabolism , Cholinergic Fibers/drug effects , Cholinergic Fibers/metabolism , Dendrites/drug effects , Dendrites/metabolism , Dendrites/pathology , Docosahexaenoic Acids/metabolism , Drug Resistance/physiology , Female , Food, Formulated , Membrane Lipids/metabolism , N-Methylaspartate/antagonists & inhibitors , Nerve Degeneration/metabolism , Neurons/metabolism , Neurons/pathology , Neuroprotective Agents/metabolism , Pregnancy , Rats , Rats, Wistar , Receptor, Nerve Growth Factor , Receptors, Nerve Growth Factor/metabolism , Treatment Outcome
4.
Orv Hetil ; 141(14): 739-40, 2000 Apr 02.
Article in Hungarian | MEDLINE | ID: mdl-10803018
SELECTION OF CITATIONS
SEARCH DETAIL
...